Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma

Patterns of care and outcome for patients with glioblastoma diagnosed during 2008-2010 in Spain

(2013) F. Graus et al.   NEURO-ONCOLOGY

Network Signatures of Survival in Glioblastoma Multiforme

(2013) Vishal N. Patel et al.   PLoS Computational Biology

Impact of radiotherapy delay on survival in glioblastoma

(2012) Izaskun Valduvieco et al.   Clinical & Translational Oncology

Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy

(2012) Georges Noel et al.   JOURNAL OF NEURO-ONCOLOGY

Delayed initiation of radiotherapy for glioblastoma: how important is it to push to the front (or the back) of the line?

(2011) Yaacov Richard Lawrence et al.   JOURNAL OF NEURO-ONCOLOGY

The timing of cranial radiation in elderly patients with newly diagnosed glioblastoma multiforme

(2011) R. Lai et al.   NEURO-ONCOLOGY

Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

(2010) Roel G.W. Verhaak et al.   CANCER CELL

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

Les délais au diagnostic et à la mise en traitement n’altèrent pas les résultats des traitements délivrés aux patients atteints de glioblastome

(2008) G. Noël et al.   Cancer Radiotherapie

Short Delay in Initiation of Radiotherapy May Not Affect Outcome of Patients With Glioblastoma: A Secondary Analysis From the Radiation Therapy Oncology Group Database

(2008) Deborah T. Blumenthal et al.   JOURNAL OF CLINICAL ONCOLOGY

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

(2008) Roger McLendon et al.   NATURE

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3

(2007) Thierry Gorlia et al.   LANCET ONCOLOGY